Some clinical trials require that an independent committee of clinical experts be established to review and adjudicate endpoint data and/or different types of clinical events. Within the Clinical Safety Department, the Medpace Clinical Endpoints team specializes in management of these committees and facilitation of adjudication processes in a variety of different therapeutic areas including: Infectious Disease, Oncology, Cardiovascular, Hepatic, Renal, Medical Device, and Rare Diseases.
Medpace is a full-service clinical contract research organization (CRO). We provide Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Our mission is to accelerate the global development of safe and effective medical therapeutics through its scientific and disciplined approach. We leverage local regulatory and therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system, anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, employing more than 4,000 people across almost 40 countries.
People. Purpose. Passion. Make a Difference Tomorrow. Join Today
The work we’ve done over the past 30 years has positively impacted the lives of countless patients and families who face hundreds of diseases across all key therapeutic areas. The work we do today will improve the lives of people living with illness and disease in the future.
Medpace Celebrates 30 Years
As we celebrate 3 decades of industry expertise and organic growth, we recognize the global team responsible for driving clinical development at Medpace. Click here to learn more about Medpace Celebrating 30 Years.
What to Expect Next:
A Medpace team member will review your qualifications and, if interested, you will be contacted with details for next steps.
Software Powered by iCIMS